Apple (NASDAQ:AAPL) , which designs and sells smartphones, computers, tablets, and accessories, closed Tuesday at $290.55, down 3.64%. The stock moved lower as investors reacted to WWDC 2026 “Apple Intelligence” and Siri AI announcements that many viewed as underwhelming and are now watching how quickly new AI features drive device upgrades and monetization. The company’s trading volume reached 69...
Apple (NASDAQ:AAPL) , which designs and sells smartphones, computers, tablets, and accessories, closed Tuesday at $290.55, down 3.64%. The stock moved lower as investors reacted to WWDC 2026 “Apple Intelligence” and Siri AI announcements that many viewed as underwhelming and are now watching how quickly new AI features drive device upgrades and monetization. The company’s trading volume reached 69.2 million shares, which is about 51% above compared with its three-month average of 45.8 million shares. Apple went public in 1980 and has grown 226273% since its IPO. S&P 500 (SNPINDEX:^GSPC) slipped 0.26% to 7,386, while the Nasdaq Composite (NASDAQINDEX:^IXIC) fell 0.97% to 25,679 as large-cap tech underperformed. Within consumer electronics, industry peers Microsoft (NASDAQ:MSFT) closed at $403.41, down 2.02%, while Alphabet (NASDAQ:GOOGL) finished at $362.29, up 0.31%, reflecting mixed reactions to AI-related headlines. Continue reading
GM plans to revamp its energy business and place a big bet on sodium-ion batteries just as shares of rival Ford got a boost from a similar move a few weeks ago.
GM plans to revamp its energy business and place a big bet on sodium-ion batteries just as shares of rival Ford got a boost from a similar move a few weeks ago.
Qualcomm (NasdaqGS:QCOM) and Primax Electronics have launched an AI powered enterprise conference platform built around Qualcomm's Dragonwing processor. The new solution targets meeting rooms and workplace collaboration, aiming to bring Edge AI capabilities directly into conference infrastructure. The partnership reflects Qualcomm's push beyond mobile devices into broader Edge AI use cases for ent...
Qualcomm (NasdaqGS:QCOM) and Primax Electronics have launched an AI powered enterprise conference platform built around Qualcomm's Dragonwing processor. The new solution targets meeting rooms and workplace collaboration, aiming to bring Edge AI capabilities directly into conference infrastructure. The partnership reflects Qualcomm's push beyond mobile devices into broader Edge AI use cases for enterprise customers. For you as an investor, this development shows how Qualcomm is working to...
Aurora Innovation (NASDAQ:AUR) , a self-driving hardware and software developer, closed at $6.16, down 1.60%. Shares are reacting to ongoing pressure from Uber (NYSE:UBER) ’s recent block sale and broader weakness in autonomous-driving names. Investors are also watching execution on driverless truck deployments and platform launches. Trading volume reached 59.8 million shares, coming in about 132%...
Aurora Innovation (NASDAQ:AUR) , a self-driving hardware and software developer, closed at $6.16, down 1.60%. Shares are reacting to ongoing pressure from Uber (NYSE:UBER) ’s recent block sale and broader weakness in autonomous-driving names. Investors are also watching execution on driverless truck deployments and platform launches. Trading volume reached 59.8 million shares, coming in about 132% above its three-month average of 25.8 million shares. Aurora Innovation IPO'd in 2021 and has fallen 38% since going public. The S&P 500 (SNPINDEX:^GSPC) slipped 0.26% to close at 7,386, while the Nasdaq Composite (NASDAQINDEX:^IXIC) declined 0.97% to close at 25,679. Among self-driving technology peers, Alphabet (NASDAQ:GOOGL) closed at $364.26 (+0.26%) and Tesla (NASDAQ:TSLA) closed at $396.68 (-3.00%), underscoring mixed sentiment across autonomous-vehicle players. Aurora Innovation shares have been under pressure for almost a month since Uber, its largest shareholder, announced it was raising capital and using some of its Aurora ownership as collateral. Aurora shares are down 25% since May 14. Continue reading
A number of stocks fell in the afternoon session after the midday Apache helicopter incident over the Strait of Hormuz removed the stable macro backdrop the semiconductor sector needed to extend its recovery.
A number of stocks fell in the afternoon session after the midday Apache helicopter incident over the Strait of Hormuz removed the stable macro backdrop the semiconductor sector needed to extend its recovery.
D2L press release ( DTOL:CA ): Q1 GAAP EPS of $0.03. Revenue of $57.13M (+8.1% Y/Y). More on D2L D2L Inc. (DTOL:CA) Q4 2026 Earnings Call Transcript Historical earnings data for D2L Financial information for D2L
D2L press release ( DTOL:CA ): Q1 GAAP EPS of $0.03. Revenue of $57.13M (+8.1% Y/Y). More on D2L D2L Inc. (DTOL:CA) Q4 2026 Earnings Call Transcript Historical earnings data for D2L Financial information for D2L
The S&P 500 (SNPINDEX:^GSPC) fell 0.26% to 7,386.65, the Nasdaq Composite (NASDAQINDEX:^IXIC) slid 0.97% to 25,678.82 in a renewed tech and chip sell‑off, while the Dow Jones Industrial Average (DJINDICES:^DJI) edged up 0.17% to 50,872.11 after a late rebound from session low
The S&P 500 (SNPINDEX:^GSPC) fell 0.26% to 7,386.65, the Nasdaq Composite (NASDAQINDEX:^IXIC) slid 0.97% to 25,678.82 in a renewed tech and chip sell‑off, while the Dow Jones Industrial Average (DJINDICES:^DJI) edged up 0.17% to 50,872.11 after a late rebound from session low
Skillsoft (SKIL) delivered earnings and revenue surprises of +2,220.00% and -21.95%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Skillsoft (SKIL) delivered earnings and revenue surprises of +2,220.00% and -21.95%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Cracker Barrel (CBRL) delivered earnings and revenue surprises of +165.17% and +2.84%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Cracker Barrel (CBRL) delivered earnings and revenue surprises of +165.17% and +2.84%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) delivered earnings and revenue surprises of -11.54% and +4.03%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) delivered earnings and revenue surprises of -11.54% and +4.03%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
Summit Therapeutics ( SMMT ) announced on Tuesday that it has commenced an underwritten public offering of $500M of shares of its common stock. Shares of SMMT slipped over 9% in extended trading on Tuesday. All the shares in the proposed offering are being offered by Summit. In addition, Summit intends to grant the underwriters a 30-day option to purchase up to an additional $75M of shares of its ...
Summit Therapeutics ( SMMT ) announced on Tuesday that it has commenced an underwritten public offering of $500M of shares of its common stock. Shares of SMMT slipped over 9% in extended trading on Tuesday. All the shares in the proposed offering are being offered by Summit. In addition, Summit intends to grant the underwriters a 30-day option to purchase up to an additional $75M of shares of its common stock at the public offering price, less underwriting discounts and commissions. Summit intends to use the net proceeds from the proposed offering, together with its existing cash, and cash equivalents, to fund the research and development of its lead product candidate, ivonescimab, and for working capital and other general corporate purposes. J.P. Morgan, Goldman Sachs & Co., and Citigroup are acting as joint book-running managers for the proposed offering. Source: press release More on Summit Therapeutics Summit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript Summit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress - Slideshow Summit Therapeutics Inc. (SMMT) Discusses Plenary Session Updates and Recent Clinical Data Following Major Oncology Congress Transcript These 10 large-cap U.S. healthcare companies carry the market's most expensive valuations Summit falls despite phase 3 ivonescimab data in NSCLC